{
    "clinical_study": {
        "@rank": "45434", 
        "brief_summary": {
            "textblock": "To evaluate the safety and tolerance of topical cidofovir (HPMPC) therapy for condyloma\n      acuminatum in patients with HIV infection. To investigate whether topical HPMPC therapy can\n      induce regression of condyloma acuminatum in patients with HIV infection."
        }, 
        "brief_title": "The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients", 
        "condition": [
            "HIV Infections", 
            "Condyloma Acuminata"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Condylomata Acuminata"
            ]
        }, 
        "detailed_description": {
            "textblock": "Four groups of 10 patients each receive topical HPMPC at  0.3 percent concentration for 5 or\n      10 days total or 1.0 percent concentration for 5 or 10 days total, followed by 2 weeks of\n      rest. When six patients at a given dose and schedule have completed treatment and follow-up\n      without significant toxicity, subsequent patients are entered at the next higher dose level.\n      Patients are evaluated twice weekly during treatment and once weekly during the rest period.\n      HPMPC may be extended for up to two additional courses in patients who experience no\n      significant toxicity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  AZT, ddI, ddC, d4T, or 3TC.\n\n          -  Oral trimethoprim/sulfamethoxazole.\n\n          -  Aerosolized pentamidine.\n\n          -  Dapsone.\n\n          -  Fluconazole.\n\n          -  Rifabutin.\n\n          -  Clarithromycin.\n\n        Patients must have:\n\n          -  HIV seropositivity.\n\n          -  Mean CD4 count >= 100 cells/mm3.\n\n          -  External anogenital condyloma acuminatum confirmed by biopsy, present for less than 1\n             year. NOTE:\n\n          -  Warts on anal, urethral, or vaginal mucosa will not be studied.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Active lesions of genital herpes, other skin wounds, or active inflammatory skin\n             disorders in the same area as warts to be treated.\n\n          -  Active medical problems sufficient to hinder study compliance.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Podofilox or any podophyllum resin preparation.\n\n          -  Liquid nitrogen treatment.\n\n          -  Interferon alpha.\n\n          -  Trichloracetic acid.\n\n          -  Other treatments, topical or systemic, surgical or ablative, known to have\n             anti-papilloma activity.\n\n          -  Other investigative drugs (except d4T or 3TC) unless approved by the sponsor.\n\n        Patients with the following prior conditions are excluded:\n\n        History of untreated syphilis or Bowenoid papulosis.\n\n        Prior Medication:\n\n        Excluded within 4 weeks prior to study entry:\n\n          -  Treatment for anogenital warts.\n\n          -  Immunomodulators (including interferons or systemic corticosteroids).\n\n          -  Lymphocyte replacement therapy.\n\n          -  Biologic response modifiers. Substance abuse."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "40", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002327", 
            "org_study_id": "219A", 
            "secondary_id": "GS-93-302"
        }, 
        "intervention": {
            "intervention_name": "Cidofovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Cidofovir"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Antiviral Agents", 
            "Condylomata Acuminata", 
            "cidofovir"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94705"
                    }, 
                    "name": "East Bay AIDS Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "941430316"
                    }, 
                    "name": "Univ California San Francisco"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "802044507"
                    }, 
                    "name": "City and County of Denver / Dept of Health & Hosps"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10453"
                    }, 
                    "name": "Bronx-Lebanon Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ of Rochester Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77006"
                    }, 
                    "name": "Houston Clinical Research Network"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77027"
                    }, 
                    "name": "Dr Brad Bowden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nassau Bay", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77058"
                    }, 
                    "name": "Dr Stephen Tyring"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "Univ of Utah School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98122"
                    }, 
                    "name": "Univ of Washington / Viral Disease Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98144"
                    }, 
                    "name": "Pacific Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Condyloma Acuminatum in Patients With HIV Infection", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "reference": {
            "citation": "Douglas J, Corey L, Tyring S, Kriesel J, Bowden B, Crosby D, Berger T, Conant M, McGuire B, Jaffe HS. A phase I/II study of cidofovir topical gel for refractory condyloma acuminatum in patients with HIV infection. Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:126 (abstract no 334)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002327"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 1997"
    }, 
    "geocoordinates": {
        "Bronx-Lebanon Hosp Ctr": "40.85 -73.867", 
        "City and County of Denver / Dept of Health & Hosps": "39.739 -104.985", 
        "Dr Brad Bowden": "29.76 -95.369", 
        "Dr Stephen Tyring": "29.545 -95.091", 
        "East Bay AIDS Ctr": "37.872 -122.273", 
        "Houston Clinical Research Network": "29.76 -95.369", 
        "Pacific Med Ctr": "47.606 -122.332", 
        "Univ California San Francisco": "37.775 -122.419", 
        "Univ of Rochester Med Ctr": "43.161 -77.611", 
        "Univ of Utah School of Medicine": "40.761 -111.891", 
        "Univ of Washington / Viral Disease Clinic": "47.606 -122.332"
    }
}